| Literature DB >> 23859613 |
Maria Victoria Ruiz-Perez, Francisca Sanchez-Jimenez, Francisco J Alonso, Juan A Segura, Javier Marquez, Miguel Angel Medina1.
Abstract
Tumor cells suffer a metabolic reprogramming which allows them to use metabolic fuels (glucose, glutamine, lipids) through anabolic fates to support their enhanced proliferation and other carcinogenesis-related features. The present review tries to address and summarize the broad and growing information available about this reprogramming, whose pieces, put together, make up a complex scheme that encompasses different complexity scales, from cells to systemic networks.Entities:
Mesh:
Substances:
Year: 2014 PMID: 23859613 DOI: 10.2174/13816128113199990482
Source DB: PubMed Journal: Curr Pharm Des ISSN: 1381-6128 Impact factor: 3.116